Matinas BioPharma Holdings, Inc. (MTNB) Stock Chart

NYSE American: MTNBInteractive price chart with technical indicators, performance and price history.

MTNB price chart

Daily prices adjusted for splits and dividends. 1D and 5D show delayed intraday prices. Markers: E earnings, D dividend, S split.

Technical snapshot

Key levels & statistics

MTNB performance vs the market

Total return, dividends reinvested

MTNB monthly returns

MTNB historical prices

MTNB dividends & splits

About the MTNB chart

Matinas BioPharma (MTNB) closed at $2.37 on October 16, 2026, down 73.0% so far this year. The stock is trading 68.0% below its 200-day moving average of $7.40, which technical analysts usually read as a long-term downtrend. Over the past year MTNB returned −90.8% including dividends, behind the S&P 500 (+16.8%).

This page charts the full trading history of Matinas BioPharma Holdings, Inc. stock. Daily prices come from EODHD and are adjusted for stock splits and dividends, so returns over long periods are comparable. For the latest quote, company profile, earnings and news, see the MTNB stock overview.

MTNB chart FAQ

Is MTNB above its 200-day moving average?

No. On October 16, 2026 MTNB closed at $2.37, 68.0% below its 200-day simple moving average of $7.40. The 50-day average was $2.89.

How has MTNB stock performed compared with the S&P 500?

Including reinvested dividends, MTNB returned −90.8% over the past year, compared with +16.8% for the S&P 500 (SPY). Over five years the figures were −99.7% and +83.0%.

Does Matinas BioPharma pay a dividend?

Matinas BioPharma has not paid a dividend in the past 12 months.

Has MTNB stock ever split?

MTNB has split its stock 2 times: 1:50 (September 3, 2024), 1:15 (September 28, 2026). Prices on this chart are adjusted for all splits.

How do I read the MTNB chart?

Pick a time range above the chart and choose candlesticks, a line or an area chart. Moving averages, Bollinger Bands, volume, RSI and MACD can be switched on with the indicator buttons, and "Compare" plots MTNB against the S&P 500, its sector or a competitor as a percentage change. Chart prices are adjusted for splits and dividends.

Biotechnology stock charts